ArticleBriefings in bioinformatics2025
Artificial intelligence-driven framework for discovering synthetic binding protein-like scaffolds from the entire protein universe.
Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial intelligence driven protein design and sustainable nanomedicine for advanced theranostics.Bioactive materials · 2026Review
- Biological Nanoscaffolds from Hierarchical Construction to Applications.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Compared to traditional sequence-based methods, artificial intelligence (AI) approaches offer distinct advantages, such as significantly improved structural recognition efficiency and the ability to overcome inherent limitations of sequence alignment. Here, we introduce an AI-driven framework designed to discover synthetic binding proteins (SBPs)-like scaffolds from the entire known proteome. The framework integrates a deep learning-based FoldSeek with our in-house developed holistic protein attributes assessment (HP2A) algorithm, and enables subsequent protein function annotation and evolutionary analysis. As a proof-of-concept, four representative SBPs, including Affibody, Anticalin, DARPin, and Fynome, were used as query to discover SBP-like scaffolds. The results demonstrate that some of the identified SBP-like proteins, despite their low sequence similarity (identity ≤0.3), exhibit significant structural resemblance to the templates (template modeling score (TM-score) ≥ 0.5), highlighting the large sequence space available within specific protein scaffold. Statistical analysis identifies key biophysical properties that contribute to privileged scaffold functionality. Additionally, evolutionary insights derived from potential SBP-like scaffolds provide valuable guidance for protein binder design, as validated through targeted sequence analysis and in silico site-directed mutagenesis. This work highlights the potential of our framework to facilitate the discovery of high-quality engineered protein scaffolds, paving the way for the development of novel SBPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.